|
| |
Institut Synthelabo SANOFI Pages on BioPortfolio:
BioPortfolio - sanofi-synthelabo
Institut fur Klinische Pharmakologie, Medizinische Fakultat, TU Dresden,, MMW Fortschr Med. 2004 Aug 5;146 Suppl 2:45-50. →View more sanofi-synthelabo ...
http://www.bioportfolio.com/biocorporate/9150-sanofi-synthel...
|
BioPortfolio Institut Synthelabo SANOFI
BioPortfolio Institut Synthelabo SANOFI BioPortfolio sanofi aventis pharma research frankfurt BioPortfolio Sanofi Synthelabo Pharmaceuticals ...
http://www.bioportfolio.com/search/Institut_Synthelabo_SANOF...
|
BioPortfolio - Sanofi-Aventis FR tel
CEA and Institut Pasteur in France, Frankfurt University in . ... BioPortfolio - Sanofi Synthelabo Pharmaceuticals BioPortfolio - Sanofi-Aventis FR tel ...
http://www.bioportfolio.com/search/Sanofi-Aventis__FR_tel.ht...
|
BioPortfolio - sanofi synthelabo uk
If Sanofi-Synthélabo is successful in its takeover bid for Aventis, what will be the effect on .... Paterson Institute for Cancer Research; Manchester, UK . ...
http://www.bioportfolio.com/search/sanofi_synthelabo_uk.html...
|
BioPortfolio - sanofi aventis pharma research frankfurt
CEA and Institut Pasteur in France, Frankfurt University in . ... Sanofi-Aventis Japan To Merge Sanofi-Synthelabo (SNY) And .. ...
http://www.bioportfolio.com/search/sanofi_aventis_pharma_res...
|
BioPortfolio - Somerset Pharmaceuticals 2007
Intergen Biomanufacturing | serum institute pune | t | Somerset Pharmaceuticals 2007 . ... BioPortfolio - Sanofi-Synthelabo Pharmaceuticals Incorporated ...
http://www.bioportfolio.com/search/Somerset_Pharmaceuticals_...
|
Btech News - MEDMONITOR - Pearls from Recent Medical Journals and ...
Investigators screened 6000 compounds from the National Cancer Institute ... such as the recently FDA-approved Arixtra from Sanofi-Synthélabo (Paris: SASY) ...
http://www.bioportfolio.com/news/btech_123101_1.htm...
|
BioPortfolio Saegis Pharmaceuticals Inc
BioPortfolio SanofiSynthelabo Pharmaceuticals Incorporated ... from The Stanley Medical Research Institute to support the SOURCE Saegis Pharmaceuticals Inc ...
http://www.bioportfolio.com/search/Saegis_Pharmaceuticals_In...
|
BioPortfolio - surviving with confidence sanofi
1/88 SANOFI-SYNTHELABO RESEARCH 9 Great Valley Parkway Malvern, PA . ... Kowa Research Institute, Nitrox LLC, Sanofi-Aventis, and Vertex. ...
http://www.bioportfolio.com/search/surviving_with_confidence...
|
BioPortfolio - almirall prodesfarma *address*
Full Alphabetic List - Institute for Ageing and Health - Newcastle . ... GERBIN was developed by Almirall Prodesfarma and licensed to Sanofi-Synthelabo . ...
http://www.bioportfolio.com/search/almirall_prodesfarma_*add...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - sanofi-synthelabo
Institut fur Klinische Pharmakologie, Medizinische Fakultat, TU Dresden,, MMW Fortschr Med. 2004 Aug 5;146 Suppl 2:45-50. →View more sanofi-synthelabo ...
http://www.bioportfolio.com/biocorporate/9150-sanofi-synthel...
|
Dronedarone (Sanofi-Synthélabo). [IDrugs. 2001] - PubMed Result
Dronedarone (Sanofi-Synthélabo). Le Grand B. Institut de Recherche Pierre Fabre, Division of Cardiovascular Diseases II, 17 avenue Jean Moulin, ...
http://www.ncbi.nlm.nih.gov/pubmed/16012904...
|
The Essentials of GI Malignancies: Maximizing the Therapeutic ...
The Postgraduate Institute for Medicine (PIM), M2 Communications and Sanofi-Synthelabo do not recommend the use of any agent outside of the labeled ...
http://www.medscape.com/viewprogram/3819_authors...
|
BioPortfolio - Sanofi-Aventis FR tel
CEA and Institut Pasteur in France, Frankfurt University in . ... BioPortfolio - Sanofi Synthelabo Pharmaceuticals BioPortfolio - Sanofi-Aventis FR tel ...
http://www.bioportfolio.com/search/Sanofi-Aventis__FR_tel.ht...
|
Therapeutic Challenges in the Treatment of Cardiovascular Diseases ...
Director, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee ... Inc., Sanofi-Synthelabo Inc.; Grant Support: Bristol-Myers Squibb Company, ...
http://www.medscape.com/viewprogram/2891_authors...
|
NIH News Release--New Drug Regimen Shows Clear Benefit for ...
Sponsored by the National Cancer Institute (NCI), the trial has been conducted by ... Sanofi-Synthelabo is also establishing an expanded access program for ...
http://www.nih.gov/news/pr/may2002/nci-18.htm...
|
Pleconaril Sanofi Synthélabo/ViroPharma. [Curr Opin Investig Drugs ...
Pleconaril Sanofi Synthélabo/ViroPharma. Billich A. Novartis Research Institute, General Dermatology, PO Box 80, Brunner Strasse 59, A-1235, Vienna, ...
http://www.ncbi.nlm.nih.gov/pubmed/11249712...
|
The GI Cancer Challenge: Establishing Treatment Strategies Within ...
Disclosure: Grants/Research Support: National Cancer Institute, ... Pfizer Inc, Sanofi-Synthelabo Inc., The Roche Group; Other Financial or Material ...
http://www.medscape.com/viewprogram/3244_authors...
|
British Journal of Pharmacology - Abstract of article: Role of ...
1Research Center Sanofi Midy, Sanofi-Synthelabo S.p.A., Via G.B. Piranesi 38, ... Dana-Farber Cancer Institute Harvard Medical School; Boston, MA ...
http://www.nature.com/bjp/journal/v140/n1/abs/0705412a.html...
|
The Endocannabinoid System: A Novel Therapeutic Target for the ...
The Discovery Institute of Medical Education requires that the faculty participating ... NCME, Sanofi-Synthelabo Inc., Vertex Pharmaceuticals Incorporated; ...
http://www.medscape.com/viewprogram/3779_authors...
|
|
